Lexicon Pharmaceuticals LXRX Earnings Call Transcripts

NASDAQ LXRX
$1.86 +0.04 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST
8 earnings calls on file for Lexicon Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Lexicon Pharmaceuticals Q3 2026 Earnings Call

Nov 5, 2026 7,502 words · 33 min read
  • Lisa DeFrancescoSVP Investor Relations and Corporate Communications
  • Mike ExtonChief Executive Officer and Director
  • Craig GranowitzSenior Vice President and Chief Medical Officer
  • Scott CoianteSenior Vice President and Chief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Lexicon Pharmaceuticals Earnings Call Transcripts

Calls8
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2020

Fiscal 2019

All 8 Lexicon Pharmaceuticals transcripts Register to get access to Lexicon Pharmaceuticals’s earnings call transcripts.